U.S. FDA Authorizes Use of AstraZeneca COVID-19 Antibody Cocktail
- Aryaman Sinha
- Dec 9, 2021
- 1 min read
The U.S. Food and Drug Administration on Wednesday authorized the use of AstraZeneca's antibody cocktail to prevent COVID-19 infections in individuals with weak immune systems or a history of severe side effects from coronavirus vaccines. Awesome!
Photo Credit: Clovis Wood Photography
Comments